Alexion Pharmaceuticals, Inc.

GLENMEDE TRUST CO NA ALXN

Report date

6/30/2021

Quarter

2021 Q2

Filed

8/16/2021

Shares

10,236

Value ($000)

1,879

Weight

0.0%

2013 Q4 - 2021 Q2 (9 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q2	8/16/2021	1,879	0.0%	10,236	6/30/2021
2021 Q1	5/18/2021	1,612	0.0%	10,557	3/31/2021
2020 Q4	2/16/2021	11,982	0.1%	76,697	12/31/2020
2020 Q3	11/16/2020	18,635	0.1%	162,862	9/30/2020
2020 Q2	8/14/2020	17,722	0.1%	157,911	6/30/2020
2020 Q1	5/20/2020	65,003	0.3%	601,053	3/31/2020
2019 Q4	2/12/2020	65,003	0.3%	601,053	12/31/2019
2014 Q1	5/7/2014	362	0.0%	2,386	3/31/2014
2013 Q4	1/31/2014	325	0.0%	2,450	12/31/2013